Tag: Tudorza

Circassia pulls plug on AZ agreement

by Selina McKee | Apr 9, 2020 | News | 0

Circassia will shed its debt to AstraZeneca under the move

Circassia takes on full US rights to AZ’ Tudorza

by Selina McKee | Dec 12, 2018 | News | 0

Circassia Pharmaceuticals is exercising an option to acquire the full US commercial rights to AstraZeneca’s Tudorza.

AZ’ Tudorza hits study goals in COPD patients with CV risk factors

by Selina McKee | Dec 5, 2017 | News | 0

AstraZeneca says top-line results from a post-marketing study show that Tudorza Pressair is effective in reducing chronic obstructive pulmonary disease (COPD) exacerbations in patients with cardiovascular issues.

Second US rejection for AZ’ potassium binder

by Selina McKee | Mar 20, 2017 | News | 0

AstraZeneca’s hyperkalaemia treatment ZS-9 has suffered another setback on the path to US approval having been rejected by regulators for the second time. The drug giant also unveiled a US-based partnership with Circassia for development and commercialisation of COPD drugs Turdoza and Duaklir.